Clinical Trials Logo

Appendicitis clinical trials

View clinical trials related to Appendicitis.

Filter by:
  • Not yet recruiting  
  • « Prev · Page 4

NCT ID: NCT02634255 Not yet recruiting - Inguinal Hernia Clinical Trials

The Onset Time of Rocuronium in Emergency and Elective Surgery

Start date: December 2015
Phase: Phase 3
Study type: Interventional

Rocuronium, a nondepolarizing neuromuscular blocking agent, is used in general anesthesia to provide conditions for endotracheal intubating. Recommended dose is 0,6 mg/kg and 90 seconds after intravenous injection, patients can be intubated. Anxiety levels may vary in patients undergoing emergency and elective surgery. Patients undergoing emergency surgery may display exaggerated laryngoscopic responses. The purpose of this study is to investigate the effect of patient anxiety levels on the onset time of rocuronium in terms of anxiety scores and train of four (TOF) 0.1 times.

NCT ID: NCT02404064 Not yet recruiting - Appendicitis Clinical Trials

Laparoscopic Appendectomy for Uncomplicated Appendicitis: Does Antimicrobial Prophylaxis Really Matter?

Start date: March 2015
Phase: N/A
Study type: Interventional

To compare surgical site infection (SSI) rate in patients undergoing laparoscopic appendectomy for acute uncomplicated appendicitis and treated with single dose regime of antibiotics versus group of patients undergoing laparoscopic appendectomy without antibiotics treatment. Patient will be given either single dose of perioperative antibiotics or no antibiotics before surgery.

NCT ID: NCT02194140 Not yet recruiting - Appendicitis Clinical Trials

Improvement of Appendix Identification and Appendicitis Diagnosis in us After Administration of Oral Contrast Medium

us
Start date: July 2014
Phase: N/A
Study type: Interventional

Rate of appendix localization on ultrasound is not high. We suggest a way to improve it's localization by oral administration of iodinated contrast material.

NCT ID: NCT01720082 Not yet recruiting - Acute Appendicitis Clinical Trials

Laparoscopic Appendectomy by Multi-port vs Single Port.

AMUSING
Start date: March 2013
Phase: Phase 3
Study type: Interventional

Laparoscopic appendectomy (LA) is nowadays considered the gold standard in fertile women affected by uncomplicated appendicitis. The level of evidence for benefits from LA in this subgroup is high. Since the dissemination of single access surgery (no-scars surgery) ameliorated outcome has been supposed in these patients regarding post-operative pain, hospital stay and cosmetics results, and keeping the same safety as LA. This randomized controlled study is supposed to give answers to these questions.

NCT ID: NCT01567098 Not yet recruiting - Appendicitis Clinical Trials

Single Incision Versus Conventional 3-Port Laparoscopic Appendectomy

Start date: June 2012
Phase: N/A
Study type: Interventional

A randomized trial to study the null hypothesis:" single incision appendectomy does not take longer operation time when compared to conventional 3-port appendectomy". The study will be carried out in a tertiary referral center in Hong Kong with a catchment population of 1 million.

NCT ID: NCT01420367 Not yet recruiting - Appendicitis Clinical Trials

Are Post-operative Antibiotics Indicated in Simple Appendicitis?

Start date: November 2011
Phase: N/A
Study type: Interventional

Hypothesis: A single dose of prophylactic antibiotics is as effective as a three dose regime in preventing post-operative complications in paediatric patients with simple appendicitis. This project will compare patients 16 years and under with simple appendicitis (appendicitis that is not perforated or gangrenous). Patients will be randomly divided into two groups; - Group one will receive a single pre-operative dose of antibiotics (metronidazole 12.5mg/kg up to 500mg and cefazolin 25mg/kg up to 1g) and two 'doses' of normal saline (placebo) eight and sixteen hours after the initial dose, respectively. - Group two will receive one pre-operative dose of antibiotics (metronidazole 12.5mg/kg up to 500mg and cefazolin 25mg/kg up to 1g) and two post-operative doses, eight and sixteen hours after the first dose, respectively. Group allocation will be concealed from the patient and their guardian, the treating surgical team and outcome assessors (triple blinded). A process to rapidly reveal group allocation if required will be in place. The aim of the study is to determine if a single dose of antibiotics is as effective as three doses in preventing post-operative infection. This will be assessed by comparing: - Duration of hospital stay from operation until discharge, based on a standardised discharge criteria. - Development of wound infection or requirement of antibiotics in the six weeks post-operation - Need for re-admission. Information will be collected prospectively from each patient's hospital notes and from a follow-up phone call six weeks after the operation.